We now have Quarter 4 H1B visa FY 2023 data and Quarter 4 PERM visa FY 2023 data and Quarter 4 H2A visa FY 2023 data.
Employer Search tool is moved to it's own page: "H1B Visa Data Search Tool"

Statistics and Summary

Ross Carly has been assisting clients through the H1B Visa process since 2017.

As of 2022, Ross Carly has succesfully submitted and recieved certification for 421 cases.

Ross Carly is located in Toronto, , and has represented 14 employers for the H1B Visa Process

434
Cases Handled
421
Cases Certified
97.00%
Approval

Cases Handled by Ross Carly

Case Number Case Status Job Title Industry Name Employer Name Year
I-200-19070-455454 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19070-138031 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19070-119662 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19070-100572 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19064-220287 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19058-661634 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19056-307634 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19053-649317 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-19053-487753 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2019
I-200-18143-510596 CERTIFIED Biochemists And Biophysicists Research And Development In The Physical Engineering And Life Sciences Amgen Inc 2018